4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-042811
President sold 25,000 shares at an average $128.62 ($3,215,458)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2021-06-21 | Sale | −1,171 | $125.58 | $147,054 | 646,836 | D |
| Novak Rodger President | 2021-06-21 | Sale | −881 | $126.62 | $111,552 | 645,955 | D |
| Novak Rodger President | 2021-06-21 | Sale | −2,969 | $127.71 | $379,171 | 642,986 | D |
| Novak Rodger President | 2021-06-21 | Sale | −12,630 | $128.76 | $1,626,239 | 630,356 | D |
| Novak Rodger President | 2021-06-21 | Sale | −7,299 | $129.46 | $944,929 | 623,057 | D |
| Novak Rodger President | 2021-06-21 | Sale | −50 | $130.27 | $6,514 | 623,007 | D |
| Open-market sales · 25,000 sh · avg $128.62 · $3,215,458 | |||||||
Loading xslF345X03/doc4.xml…